Patents by Inventor Laszlo Nemes

Laszlo Nemes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050288264
    Abstract: Abstract of the Disclosure The invention relates to a dosage regimen for emergency contraception, to pharmaceutical compositions of the same purpose, to the use of levenorgestrel for the manufacture of pharmaceutical compositions for the same purpose, as well as to the manufacturing process of these pharmaceutical compositions. According to the invention the emergency contraception carried out by the use of levonorgestrel as active ingredient is characterised by administering a single application dose containing 1.5 ± 0.2 mg of levonorgestrel as active ingredient up to 72 hours after the coitus. The pharmaceutical compositions for emergency contraception according to the invention contain only 1.5 ± 0.2 mg of levonorgestrel as active ingredient in each application dose in admixture with known excipients, diluents, flavoring or aromatizing, stabilizers, as well as formulation-promoting or formulation-providing additives, commonly used in the pharmaceutical practice.
    Type: Application
    Filed: October 5, 2004
    Publication date: December 29, 2005
    Inventors: Paul VAN LOOK, Illesne BALOGH, Katalin KOMANDI, Laszlo NEMES, Zsolt SZABO
  • Publication number: 20050032755
    Abstract: The invention relates to a dosage regimen for emergency contraception, to pharmaceutical compositions of the same purpose, to the use of levenorgestrel for the manufacture of pharmaceutical compositions for the same purpose, as well as to the manufacturing process of these pharmaceutical compositions. According to the invention the emergency contraception carried out by the use of levonorgestrel as active ingredient is characterised by administering a single application dose containing 1.5±0.2 mg of levonorgestrel as active ingredient up to 72 hours after the coitus. The pharmaceutical compositions for emergency contraception according to the invention contain only 1.5±0.2 mg of levonorgestrel as active ingredient in each application dose in admixture with known excipients, diluents, flavoring or aromatizing, stabilizers, as well as formulation-promoting or formulation-providing additives, commonly used in the pharmaceutical practice.
    Type: Application
    Filed: November 26, 2002
    Publication date: February 10, 2005
    Inventors: Paul Van Look, Illesne Balogh, Katalin Komandi, Laszlo Nemes, Zsolt Szabo
  • Patent number: 4010708
    Abstract: A differential pressure indicator including a remote sensing means is disclosed wherein a reference volume under predetermined pressure is employed as a standard, triggering an indicating mechanism when a second (measured) pressure falls above or below a predetermined threshold. The indicating mechanism may include a novel shaft which protrudes through the casing carrying thereon a source of radioactive material which is remotely monitored. Alternatively, the protrusion may be sensed as an impedance variation or additional visual indicator. In one embodiment, a plurality of the subject sensors are housed upon the blades of a helicopter. Upon sensing the changing pressure in the helicopter blade, the protruding element provides a radioactive source which is sensed in a conventional manner to provide a cockpit readout.
    Type: Grant
    Filed: December 2, 1975
    Date of Patent: March 8, 1977
    Assignee: Trodyne Corporation
    Inventors: Francis C. Keledy, Laszlo Nemes